| Names | |
|---|---|
| Preferred IUPAC name 4-[2-(1H-Imidazol-1-yl)ethoxy]benzoic acid | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| DrugBank |
|
| UNII | |
| |
| |
| Properties | |
| C12H12N2O3 | |
| Molar mass | 232.239 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Dazoxiben is an orally activethromboxane synthase inhibitor.[1] It has shown a significant clinical improvement in patients withRaynaud's syndrome.[2]

One convenient synthesis starts with the O-chloroethylether of p-hydroxybenzamide and proceeds bydisplacement withimidazole to give2.Hydrolysis of the amide function completes the synthesis of dazoxiben.
Thisdrug article relating to theblood andblood forming organs is astub. You can help Wikipedia byexpanding it. |